CBIO
Price
$14.79
Change
-$0.30 (-1.99%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
294.26M
21 days until earnings call
INCY
Price
$68.73
Change
+$1.06 (+1.57%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
13.1B
27 days until earnings call
Interact to see
Advertisement

CBIO vs INCY

Header iconCBIO vs INCY Comparison
Open Charts CBIO vs INCYBanner chart's image
Crescent Biopharma
Price$14.79
Change-$0.30 (-1.99%)
Volume$2.41K
Capitalization294.26M
Incyte
Price$68.73
Change+$1.06 (+1.57%)
Volume$64.77K
Capitalization13.1B
CBIO vs INCY Comparison Chart in %
Loading...
CBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBIO vs. INCY commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBIO is a Hold and INCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (CBIO: $15.09 vs. INCY: $67.67)
Brand notoriety: CBIO: Not notable vs. INCY: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBIO: 5% vs. INCY: 72%
Market capitalization -- CBIO: $294.26M vs. INCY: $13.1B
CBIO [@Biotechnology] is valued at $294.26M. INCY’s [@Biotechnology] market capitalization is $13.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBIO’s FA Score shows that 2 FA rating(s) are green whileINCY’s FA Score has 1 green FA rating(s).

  • CBIO’s FA Score: 2 green, 3 red.
  • INCY’s FA Score: 1 green, 4 red.
According to our system of comparison, CBIO is a better buy in the long-term than INCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBIO’s TA Score shows that 5 TA indicator(s) are bullish while INCY’s TA Score has 4 bullish TA indicator(s).

  • CBIO’s TA Score: 5 bullish, 6 bearish.
  • INCY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INCY is a better buy in the short-term than CBIO.

Price Growth

CBIO (@Biotechnology) experienced а -6.51% price change this week, while INCY (@Biotechnology) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

CBIO is expected to report earnings on Jul 30, 2025.

INCY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCY($13.1B) has a higher market cap than CBIO($294M). CBIO YTD gains are higher at: 5960.241 vs. INCY (-2.027).
CBIOINCYCBIO / INCY
Capitalization294M13.1B2%
EBITDAN/A407M-
Gain YTD5960.241-2.027-294,052%
P/E RatioN/A336.35-
RevenueN/A4.41B-
Total CashN/A2.41B-
Total DebtN/A43.1M-
FUNDAMENTALS RATINGS
CBIO vs INCY: Fundamental Ratings
CBIO
INCY
OUTLOOK RATING
1..100
166
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
12100
SMR RATING
1..100
9989
PRICE GROWTH RATING
1..100
3453
P/E GROWTH RATING
1..100
381
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBIO's Valuation (18) in the Biotechnology industry is significantly better than the same rating for INCY (92). This means that CBIO’s stock grew significantly faster than INCY’s over the last 12 months.

CBIO's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for INCY (100). This means that CBIO’s stock grew significantly faster than INCY’s over the last 12 months.

INCY's SMR Rating (89) in the Biotechnology industry is in the same range as CBIO (99). This means that INCY’s stock grew similarly to CBIO’s over the last 12 months.

CBIO's Price Growth Rating (34) in the Biotechnology industry is in the same range as INCY (53). This means that CBIO’s stock grew similarly to INCY’s over the last 12 months.

INCY's P/E Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for CBIO (38). This means that INCY’s stock grew somewhat faster than CBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBIOINCY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend about 1 month ago
60%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 10 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
CBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDRSF66.68N/A
N/A
MEDARTIS HOLDING AG
RTMVY21.22N/A
N/A
Rightmove Plc
HLNCF5.04-0.02
-0.40%
HALEON PLC
NBYCF0.06N/A
-3.23%
Niobay Metals Inc.
TAOIF0.09-0.01
-5.55%
TAG Oil Ltd.

CBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBIO has been loosely correlated with SAGE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CBIO jumps, then SAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBIO
1D Price
Change %
CBIO100%
-1.31%
SAGE - CBIO
42%
Loosely correlated
-0.11%
UTHR - CBIO
36%
Loosely correlated
+1.39%
NRXP - CBIO
27%
Poorly correlated
+0.30%
XLO - CBIO
26%
Poorly correlated
+1.56%
AIM - CBIO
24%
Poorly correlated
+2.82%
More

INCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with TECH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
+0.59%
TECH - INCY
41%
Loosely correlated
+2.22%
AXON - INCY
39%
Loosely correlated
-1.49%
REGN - INCY
37%
Loosely correlated
+1.79%
LGND - INCY
37%
Loosely correlated
+1.20%
SYRE - INCY
36%
Loosely correlated
+2.03%
More